Cytokine levels (IL-6 and IFN-γ), acute phase response and nutritional status as prognostic factors in lung cancer

Cytokine

Volumn 11, Issue 1, 1999, Pages 80-86

  Martín, Francisco ^a   Santolaria, Francisco ^a   Batista, Norberto ^a   Milena, Antonio ^a   González Reimers, Emilio ^a   Brito, María J ^a   Oramas, Juana ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

IFN ; IL 6; Lung cancer; Malnutrition; Survival

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTITRYPSIN; C REACTIVE PROTEIN; CYTOKINE; FERRITIN; GAMMA INTERFERON; GROWTH HORMONE; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER SURVIVAL; CYTOKINE PRODUCTION; FEMALE; FERRITIN BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033051669     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0398     Document Type: Article

References (36)

1. Nijsten MWN, Hack CE, Helle M, ten Duis HJ, Klasen HJ, Aarden LA (1991) Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery 109:761-767,
2. Ohzato H, Yoshizaki K, Nishimoto N, Ogata A, Tagoh H, Mondem M, Gotoh M, Kishimoto T, Mori T (1992) Interleukin-6 as a new indicator of inflammatory status: Detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 111:201-209.
3. Zamir O, Hasselgreen PO, Allmen D, Fischer JE (1993) In vivo administration of interleukin-1α induces muscle proteolysis in normal and adrenalectomized rats. Metabolism 42:204-208.
4. Zamir O, Hasselgreen PO, Kunkel SL, Frederick J, Higashiguchi T, Fisher JE (1992) Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch Surg 127:170-174.
5. Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RO, Jablons D (1992) Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: A possible role for interleukin 6 in cancer cachexia. Cancer Res 52:4113-4116.
6. De Wys WD, Begg C, Lavin PT, Band PR, Bennet JM, Bertino JR, Cohen MH, Douglass HO, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69:491-497.
7. Daly JM, Cech AC (1996) Nutrition and neoplasia. In Fischer JE (ed.) Nutrition and Metabolism in the Surgical Patient. Little Brown, Boston, pp. 601-621.
8. Falconer JS, Fearon KCH, Plester CE, Ross JA, Carter DC (1994) Cytokines, the acute phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 219:325-331.
9. Hyltander A, Drott CH, Körner U, Sandström R, Lundholm K (1991) Elevated energy expenditure in patients with solid tumors. Eur J Cancer 27:9-15.
10. Fredrix EWHM, Wouters EFM, Soeters PB, van der Aalst ACJM, Kester ADM, von Meyenfeldt MF, Saris VHM (1991) Resting energy expenditure in patients with non-small cell lung cancer. Cancer 68:1616-1621.
11. Staal-van den Brekel AJ, Schols AMWJ, ten Velde GPM, Buurman WA, Wouters EFM (1994) Analysis of the energy balance in lung cancer patients. Cancer Res 54:6430-6433.
12. Staal-van den Brekel AJ, Dentener MA, Schols AMWJ, Buurman WA, Wouters EFM (1995) Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 13:2600-2605.
13. Oliff A, Defeo-Jones D, Boyer M, Martínez D, Kiefer D, Vuocolo G, Wolfe A, Socher SH (1987) Tumor secreting human TNF/cachectin induce cachexia in mice. Cell 50:555-563.
14. Socher SH, Martínez D, Craig JB, Kuhn JH, Oloff A (1988) Tumor necrosis factor not detectable in patients with clinical cancer cachexia. J Natl Cancer Inst 80:595-599.
15. Strassmann G, Fong M, Kenney JS, Jacob CO (1992) Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89:1681-1684.
16. Miles SA, Rezai AR, Salazar-González JF, Vander Meyden M, Stevens RH, Logan DM, Mituyasu RT, Taga T, Hirano T, Kishimoto T, Martínez-Maza O (1990) AIDS and Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 87:4068-4072.
17. Watson JM, Sensintaffar JL, Berek JS, Martínez-Maza O (1990) Constitutive production of IL-6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res 50:6959-6965.
18. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T. (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332:83-85.
19. Yee C, Biondi A, Wang XH, Iscove NN, Sousa J, Aarden LA, Wong GG, Clark SC, Messner HA, Minden MD (1989) A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood 74:798-804.
20. Meir EV, Sawamura Y, Diserens AC, Hamou MF, Tribolet N (1990) Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res 50:6683-6688.
21. Blay JY, Negrier S, Combaret V, Attali S, Goillot E, Merrouche Y, Mercatello A, Ravault A, Tourani JM, Moscovtchenko, Philip T, Favrot M (1992) Serum level of interleukin 6 as prognosis factor in metastatic renal cell carcinoma. Cancer Res 52:3317-3322.
22. Dosquet C, Schaetz A, Faucher C, Lepage E, Wautier JL, Richard F, Cabane J (1994) Tumor necrosis factor α, interleukin-1β and interleukin-6 in patients with renal cell carcinoma. Eur J Cancer 30A: 162-167.
23. Kurzrock R, Redman J, Cabanillas F, Jones D, Rothberg J, Talpaz M (1993) Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin' disease and with B sumptoms. Cancer Res 53:2118-2122.
24. Berek JS, Chung C, Kaldi K, Watson JM, Knox RM, Martínez-Maza O (1991) Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol 164:1038-1043.
25. Bataille R, Jourdan M, Zhang XG, Klein B (1989) Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell discrasias. J Clin Invest 84:2008-2011.
26. Pelliniemi TT, Irjala K, Mattila K, Pulkki, Rajamäki A, Tienhaara A, Laakso M (1995) Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Blood 85:765-771.
27. Lanzotti VJ, Thomas DR, Boyle LE, Smith TL, Gehan EA, Samuels ML (1997) Survival with inoperable lung cancer. Cancer 39:303-313.
28. Yanagawa H, Sone S, Takahashi Y, Yano H, Shinohara T, Ogura T (1995) Serum levels of interleukin 6 in patients with lung cancer. Br J Cancer 71:1095-1098.
29. Osterlind K, Andersen PK (1986) Prognostic factors in small cell lung cancer: Multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 46:4189-4194.
30. Mountain CF (1986) A new international staging system for lung cancer. Chest 89 (Suppl.): 225-323.
31. Hannisdal E, Engan T (1991) Blood analyses and survival in symptom- and survey-detected lung cancer patients. J Intern Med 229:337-341.
32. McCann SM, Karanth S, Kamat A, Les Dees W, Lyson K, Gimeno M, Rettori V (1995) Role of cytokines in hypothalamic-pituitary functions. In Aggarwal BB, Puri RK (eds), Human Cytokines its Role in Disease and Therapy, Blackwell, Cambridge, MA, pp. 293-303.
33. Scott HR, McMillan DC, Crilly A, McArdle CS, Milroy R (1996) The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. Br J Cancer 73:1560-1562.
34. Zelen M (1973) Keynote address on biostatistics and data retrieval. Cancer Chem Rep 4:31-42.
35. Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, Smith MF (1977) Nutritional and metabolic assessment of the hospitalized patient. J Parenter Enteral Nutr 1:11-22.
36. González Hermoso F, Porta R, Herrero A (1990) Resultados del estudio antropométrico de la problación canaria adulta. (Results of an anthropometric study of the adult Canarian population from 1985 to 1987.) Nutr Hosp 5:238-247.